Cross‐linking disulfide bonds govern solution structures of diabodies

In the last years, antibodies have emerged as a promising new class of therapeutics, due to their combination of high specificity with long serum half‐life and low risk of side‐effects. Diabodies are a popular novel antibody format, consisting of two Fv domains connected with short linkers. Like IgG antibodies, they simultaneously bind two target proteins. However, they offer altered properties, given their smaller size and higher rigidity. In this study, we conducted the—to our knowledge—first molecular dynamics (MD) simulations of diabodies and find a surprisingly high conformational flexibility in the relative orientation of the two Fv domains. We observe rigidifying effects through the introduction of disulfide bonds in the Fv–Fv interface and characterize the effect of different disulfide bond locations on the conformation. Additionally, we compare VH–VL orientations and paratope dynamics between diabodies and an antigen binding fragment (Fab) of the same sequence. We find mostly consistent structures and dynamics, indicating similar antigen binding properties. The most significant differences can be found within the CDR‐H2 loop dynamics. Of all CDR loops, the CDR‐H2 is located closest to the artificial Fv–Fv interface. All examined diabodies show similar VH–VL orientations, Fv–Fv packing and CDR loop conformations. However, the variant with a P14C‐K64C disulfide bond differs most from the Fab in our measures, including the CDR‐H3 loop conformational ensemble. This suggests altered antigen binding properties and underlines the need for careful validation of the disulfide bond locations in diabodies.

[1]  A. Bujotzek,et al.  OCD.py - Characterizing immunoglobulin inter-domain orientations , 2021, bioRxiv.

[2]  E. Arnold,et al.  Co-crystallization with diabodies: a case study for the introduction of synthetic symmetry. , 2021, Structure.

[3]  F. Forneris,et al.  Inference of molecular structure for characterization and improvement of clinical grade immunocytokines. , 2021, Journal of structural biology.

[4]  Patrick K. Quoika,et al.  Surprisingly Fast Interface and Elbow Angle Dynamics of Antigen-Binding Fragments , 2020, Frontiers in Molecular Biosciences.

[5]  A. Bujotzek,et al.  Antibodies exhibit multiple paratope states influencing VH–VL domain orientations , 2020, Communications Biology.

[6]  Yoshikazu Tanaka,et al.  Association behavior and control of the quality of cancer therapeutic bispecific diabodies expressed in Escherichia coli , 2020 .

[7]  K. Liedl,et al.  T-Cell Receptor CDR3 Loop Conformations in Solution Shift the Relative Vα-Vβ Domain Distributions , 2020, Frontiers in Immunology.

[8]  Jaime Fern'andez del R'io,et al.  Array programming with NumPy , 2020, Nature.

[9]  I. Sassoon,et al.  Advances in Antibody–Drug Conjugate Design: Current Clinical Landscape and Future Innovations , 2020, SLAS discovery : advancing life sciences R & D.

[10]  A. Bujotzek,et al.  VH‐VL interdomain dynamics observed by computer simulations and NMR , 2020, Proteins.

[11]  K. Liedl,et al.  Antibody CDR loops as ensembles in solution vs. canonical clusters from X-ray structures , 2020, mAbs.

[12]  J. Reichert,et al.  Antibodies to watch in 2020 , 2019, mAbs.

[13]  K. Liedl,et al.  Transitions of CDR-L3 Loop Canonical Cluster Conformations on the Micro-to-Millisecond Timescale , 2019, Front. Immunol..

[14]  T. Hellweg,et al.  Distinguishing Between Monomeric scFv and Diabody in Solution Using Light and Small Angle X-ray Scattering , 2019, Antibodies.

[15]  Jakub Rydzewski,et al.  Promoting transparency and reproducibility in enhanced molecular simulations , 2019, Nature Methods.

[16]  Johannes L. Schönberger,et al.  SciPy 1.0: fundamental algorithms for scientific computing in Python , 2019, Nature Methods.

[17]  Janice M Reichert,et al.  Bispecific antibodies: a mechanistic review of the pipeline , 2019, Nature Reviews Drug Discovery.

[18]  R. Kontermann,et al.  Diabody-Ig: a novel platform for the generation of multivalent and multispecific antibody molecules , 2019, mAbs.

[19]  Jie-Oh Lee,et al.  Structural diversity and flexibility of diabodies. , 2019, Methods.

[20]  K. Liedl,et al.  Characterizing the Diversity of the CDR-H3 Loop Conformational Ensembles in Relationship to Antibody Binding Properties , 2019, Front. Immunol..

[21]  Daniel A. Richards,et al.  Exploring alternative antibody scaffolds: Antibody fragments and antibody mimics for targeted drug delivery. , 2018, Drug discovery today. Technologies.

[22]  Hayyoung Lee,et al.  Crystal structures of mono- and bi-specific diabodies and reduction of their structural flexibility by introduction of disulfide bridges at the Fv interface , 2016, Scientific Reports.

[23]  Jeffrey J. Gray,et al.  Large-scale sequence and structural comparisons of human naive and antigen-experienced antibody repertoires , 2016, Proceedings of the National Academy of Sciences.

[24]  James R. Apgar,et al.  Development of PF-06671008, a Highly Potent Anti-P-cadherin/Anti-CD3 Bispecific DART Molecule with Extended Half-Life for the Treatment of Cancer , 2016, Antibodies.

[25]  Thomas J Lane,et al.  MDTraj: a modern, open library for the analysis of molecular dynamics trajectories , 2014, bioRxiv.

[26]  Frank Noé,et al.  PyEMMA 2: A Software Package for Estimation, Validation, and Analysis of Markov Models. , 2015, Journal of chemical theory and computation.

[27]  C. Simmerling,et al.  ff14SB: Improving the Accuracy of Protein Side Chain and Backbone Parameters from ff99SB. , 2015, Journal of chemical theory and computation.

[28]  James Dunbar,et al.  Prediction of VH–VL domain orientation for antibody variable domain modeling , 2015, Proteins.

[29]  Irving L. Weissman,et al.  Tuning Cytokine Receptor Signaling by Re-orienting Dimer Geometry with Surrogate Ligands , 2015, Cell.

[30]  Brian D. Weitzner,et al.  The origin of CDR H3 structural diversity. , 2015, Structure.

[31]  Massimiliano Bonomi,et al.  PLUMED 2: New feathers for an old bird , 2013, Comput. Phys. Commun..

[32]  C. Deane,et al.  ABangle: characterising the VH-VL orientation in antibodies. , 2013, Protein engineering, design & selection : PEDS.

[33]  Duncan Poole,et al.  Routine Microsecond Molecular Dynamics Simulations with AMBER on GPUs. 2. Explicit Solvent Particle Mesh Ewald. , 2013, Journal of chemical theory and computation.

[34]  P. Baeuerle,et al.  Targeting T cells to tumor cells using bispecific antibodies. , 2013, Current opinion in chemical biology.

[35]  P. Kufer,et al.  Blinatumomab: a historical perspective. , 2012, Pharmacology & therapeutics.

[36]  L. Possani,et al.  A single mutation in framework 2 of the heavy variable domain improves the properties of a diabody and a related single-chain antibody. , 2012, Journal of molecular biology.

[37]  Andreas Wolf,et al.  Immunopharmacologic response of patients with B-lineage acute lymphoblastic leukemia to continuous infusion of T cell-engaging CD19/CD3-bispecific BiTE antibody blinatumomab. , 2012, Blood.

[38]  Haruki Nakamura,et al.  Computer-aided antibody design , 2012, Protein engineering, design & selection : PEDS.

[39]  Robert L. Jernigan,et al.  Protein Loop Dynamics Are Complex and Depend on the Motions of the Whole Protein , 2012, Entropy.

[40]  Hiroki Hayashi,et al.  Construction and humanization of a functional bispecific EGFR × CD16 diabody using a refolding system , 2012, The FEBS journal.

[41]  Hermann Einsele,et al.  Targeted therapy with the T-cell-engaging antibody blinatumomab of chemotherapy-refractory minimal residual disease in B-lineage acute lymphoblastic leukemia patients results in high response rate and prolonged leukemia-free survival. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[42]  Klaus R. Liedl,et al.  A challenging system: Free energy prediction for factor Xa , 2011, J. Comput. Chem..

[43]  C. Rader DARTs take aim at BiTEs. , 2011, Blood.

[44]  P. Moore,et al.  Application of dual affinity retargeting molecules to achieve optimal redirected T-cell killing of B-cell lymphoma. , 2011, Blood.

[45]  Roland L. Dunbrack,et al.  A new clustering of antibody CDR loop conformations. , 2011, Journal of molecular biology.

[46]  Andrew C. R. Martin,et al.  Analysis and prediction of VH/VL packing in antibodies. , 2010, Protein engineering, design & selection : PEDS.

[47]  Thomas Singer,et al.  The safety and side effects of monoclonal antibodies , 2010, Nature Reviews Drug Discovery.

[48]  R. Kontermann Alternative antibody formats. , 2010, Current opinion in molecular therapeutics.

[49]  Etienne Weiss,et al.  Therapeutic antibodies: successes, limitations and hopes for the future , 2009, British journal of pharmacology.

[50]  Massimiliano Bonomi,et al.  PLUMED: A portable plugin for free-energy calculations with molecular dynamics , 2009, Comput. Phys. Commun..

[51]  P. Labute proteins STRUCTURE O FUNCTION O BIOINFORMATICS Protonate3D: Assignment of ionization , 2013 .

[52]  A. Plückthun,et al.  Structure of the recombinant antibody Fab fragment f3p4. , 2008, Acta crystallographica. Section D, Biological crystallography.

[53]  M. Parrinello,et al.  Well-tempered metadynamics: a smoothly converging and tunable free-energy method. , 2008, Physical review letters.

[54]  D. Kern,et al.  Dynamic personalities of proteins , 2007, Nature.

[55]  Michael Andrec,et al.  A large data set comparison of protein structures determined by crystallography and NMR: Statistical test for structural differences and the effect of crystal packing , 2007, Proteins.

[56]  U. Wetterauer,et al.  A bispecific diabody directed against prostate-specific membrane antigen and CD3 induces T-cell mediated lysis of prostate cancer cells , 2007, Cancer Immunology, Immunotherapy.

[57]  John D. Hunter,et al.  Matplotlib: A 2D Graphics Environment , 2007, Computing in Science & Engineering.

[58]  A. Laio,et al.  A bias-exchange approach to protein folding. , 2007, The journal of physical chemistry. B.

[59]  P. Hoffmann,et al.  CD19-/CD3-bispecific antibody of the BiTE class is far superior to tandem diabody with respect to redirected tumor cell lysis. , 2007, Molecular immunology.

[60]  A. Zemla,et al.  Antibody elbow angles are influenced by their light chain class. , 2006, Journal of molecular biology.

[61]  Marvin Edelman,et al.  The limit of accuracy of protein modeling: influence of crystal packing on protein structure. , 2005, Journal of molecular biology.

[62]  C. Rapp,et al.  Crystal packing effects on protein loops , 2005, Proteins.

[63]  J. Skolnick,et al.  TM-align: a protein structure alignment algorithm based on the TM-score , 2005, Nucleic acids research.

[64]  T. L. Brown,et al.  TransMabs: cell-penetrating antibodies, the next generation , 2005, Expert opinion on biological therapy.

[65]  Dan Lu,et al.  The effect of variable domain orientation and arrangement on the antigen-binding activity of a recombinant human bispecific diabody. , 2004, Biochemical and biophysical research communications.

[66]  P. Kufer,et al.  A revival of bispecific antibodies. , 2004, Trends in biotechnology.

[67]  M. Little,et al.  Effect of linker sequences between the antibody variable domains on the formation, stability and biological activity of a bispecific tandem diabody. , 2004, Protein engineering, design & selection : PEDS.

[68]  A. Wu,et al.  The crystal structure of an anti-CEA scFv diabody assembled from T84.66 scFvs in V(L)-to-V(H) orientation: implications for diabody flexibility. , 2003, Journal of molecular biology.

[69]  B. Alberts,et al.  Molecular Biology of the Cell (4th Ed) , 2002 .

[70]  P. Carter,et al.  Bispecific human IgG by design. , 2001, Journal of immunological methods.

[71]  Guido Rossum,et al.  Python Reference Manual , 2000 .

[72]  B. Rode,et al.  Elbow flexibility and ligand-induced domain rearrangements in antibody Fab NC6.8: large effects of a small hapten. , 2000, Biophysical journal.

[73]  P. Bohlen,et al.  Acquired antagonistic activity of a bispecific diabody directed against two different epitopes on vascular endothelial growth factor receptor 2. , 1999, Journal of immunological methods.

[74]  M. Little,et al.  Bispecific tandem diabody for tumor therapy with improved antigen binding and pharmacokinetics. , 1999, Journal of molecular biology.

[75]  Michaela A. E. Arndt,et al.  A bispecific diabody that mediates natural killer cell cytotoxicity against xenotransplantated human Hodgkin's tumors. , 1999, Blood.

[76]  E. Eliopoulos,et al.  Construction and characterization of a humanized single chain Fv antibody fragment against the main immunogenic region of the acetylcholine receptor , 1999, Journal of Neuroimmunology.

[77]  B. Rode,et al.  Ligand-induced domain movement in an antibody Fab: molecular dynamics studies confirm the unique domain movement observed experimentally for Fab NC6.8 upon complexation and reveal its segmental flexibility. , 1998, Journal of molecular biology.

[78]  P. Iliades,et al.  Orientation of antigen binding sites in dimeric and trimeric single chain Fv antibody fragments , 1998, FEBS letters.

[79]  A. Lesk,et al.  Standard conformations for the canonical structures of immunoglobulins. , 1997, Journal of molecular biology.

[80]  A. George,et al.  Importance of the linker in expression of single-chain Fv antibody fragments: optimisation of peptide sequence using phage display technology. , 1997, Journal of immunological methods.

[81]  M. Bott Anaerobic citrate metabolism and its regulation in enterobacteria , 1997, Archives of Microbiology.

[82]  B. Snedecor,et al.  High Level Secretion of a Humanized Bispecific Diabody from Escherichia coli , 1996, Bio/Technology.

[83]  Payne,et al.  Periodic boundary conditions in ab initio calculations. , 1995, Physical review. B, Condensed matter.

[84]  R. Williams,et al.  Crystal structure of a diabody, a bivalent antibody fragment. , 1994, Structure.

[85]  T Prospero,et al.  "Diabodies": small bivalent and bispecific antibody fragments. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[86]  T. Darden,et al.  Particle mesh Ewald: An N⋅log(N) method for Ewald sums in large systems , 1993 .

[87]  P. Chavrier,et al.  Molecular Biology of the Cell , 1990, Color Atlas of Clinical Hematology.

[88]  A. Lesk,et al.  Canonical structures for the hypervariable regions of immunoglobulins. , 1987, Journal of molecular biology.

[89]  H. Berendsen,et al.  Molecular dynamics with coupling to an external bath , 1984 .

[90]  W. L. Jorgensen,et al.  Comparison of simple potential functions for simulating liquid water , 1983 .

[91]  T. Schneider,et al.  Molecular-dynamics study of a three-dimensional one-component model for distortive phase transitions , 1978 .

[92]  G. Ciccotti,et al.  Numerical Integration of the Cartesian Equations of Motion of a System with Constraints: Molecular Dynamics of n-Alkanes , 1977 .

[93]  R. Porter Separation and Isolation of Fractions of Rabbit Gamma-Globulin containing the Antibody and Antigenic Combining Sites , 1958, Nature.

[94]  Guy Georges,et al.  The intriguing options of multispecific antibody formats for treatment of cancer. , 2013, Cancer genomics & proteomics.

[95]  Alessandro Laio,et al.  Protein Folding and Ligand-Enzyme Binding from Bias-Exchange Metadynamics Simulations , 2012 .

[96]  Massimiliano Bonomi,et al.  Metadynamics , 2019, ioChem-BD Computational Chemistry Datasets.

[97]  A. Steinacker,et al.  A Spice Study of Silicon Sensor Strip Noise on Long Ladders , 2011 .

[98]  R. Kontermann Recombinant bispecific antibodies for cancer therapy , 2005, Acta Pharmacologica Sinica.

[99]  RolandEKONTERMANN Recombinant bispecific antibodies for cancer therapy , 2005 .

[100]  T. N. Bhat,et al.  The Protein Data Bank , 2000, Nucleic Acids Res..

[101]  E. Kabat,et al.  Sequences of proteins of immunological interest , 1991 .

[102]  Brian D. Weitzner,et al.  The Origin of CDR H 3 Structural Diversity , 2022 .